NCT05100615 is a NA clinical trial of surgery in Effects of the Elements, sponsored by Minia University.

Who is sponsoring NCT05100615?

NCT05100615 is sponsored by Minia University.

What drugs are being tested in NCT05100615?

Interventions in NCT05100615: surgery.

What condition does NCT05100615 study?

NCT05100615 studies Effects of the Elements.

Is NCT05100615 still recruiting?

NCT05100615 is currently status unknown. Last updated 20 October 2021.

Last reviewed 2021-10-20 · How we verify

NCT05100615

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Healing Assessment of Osseous Defects After Surgical Removal of Periapical Lesions in the Presence of Hydroxyapatite, Nanohydroxyapatite and Combination of Nanohydroxyapatite and Platelet-rich Fibrin. A Clinical Study

Status unknown NA Last updated 20 October 2021

What this trial tests

NA trial testing surgery in Effects of the Elements in 24 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 May 2022

1 May 2022

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	24
Start date	1 November 2021
Primary completion	1 May 2022
Estimated completion	1 May 2022
Sites	1 location across Egypt

Drugs / interventions tested

surgery

Conditions studied

Effects of the Elements — all drugs for Effects of the Elements →

Sponsor

Minia University

Who can join

Adults 20 to 45, any sex, with Effects of the Elements. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

healing of periapical lesion
Time frame: interappointment at 1 month, 3 months and 6 months
change in size of bony defect

Sponsor's own description

recruited patients with periapical lesions will be divided into three groups and surgically treated with three types of bone graft (hydroxyappatite, nanohydroxyappatite and PRF WITH NANOHYDROXTAPPATITE) and then evaluated for month, three months and six months for the healing of periapical bone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of surgery

Trials testing the same drug.

NCT07135336 — Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment · recruiting
NCT06912711 — TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma · Phase 2 · recruiting
NCT06944470 — JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC · Phase 2 · not yet recruiting
NCT06915909 — Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial · NA · not yet recruiting
NCT06751394 — Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer · Phase 2 · not yet recruiting

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05100615 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 20 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing